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Mutant mice lacking the integrin 
 
 
 
8 subunit exhibit vari-
able defects in kidney development with most mutants
missing both kidneys. Several lines of evidence indicate
that the known extracellular matrix ligands for integrin
 
 
 
8
 
 
 
1 are either dispensable for or not involved in 
 
 
 
8
 
 
 
1
signaling during kidney development. This suggests the
presence of an unknown ligand. A novel 
 
 
 
8
 
 
 
1 ligand,
nephronectin, has now been identiﬁed. Nephronectin is a
new extracellular matrix protein associated with the Wolf-
ﬁan duct and the ureteric bud, epithelial structures with
well-deﬁned roles in kidney development.
 
Congenital abnormalities of the kidney and urinary tract are
 
relatively common in the human population, affecting 
 
 
 
0.5%
of pregnancies. The most severe congenital defects, such as bi-
lateral renal agenesis (absence of both kidneys), result in death
shortly after birth, whereas the more common milder anoma-
lies result in dysplasia, cysts, stone formation, vesicoureteral re-
flux, and sometimes renal failure (Pope et al., 1999; Glassock
and Massry, 2001). A better understanding of the mechanisms
which regulate both kidney and ureter development at the
molecular level is essential for effective treatment and preven-
 
tion of these congenital disorders. In this issue, Branden-
berger et al. (2001) report the identification of nephronectin,
a novel extracellular matrix molecule likely to have an impor-
tant role in kidney development. Understanding the biology
of nephronectin should improve prospects for elucidating the
causes of congenital kidney malformations.
The developing kidney continues to be an excellent model
system for investigating the inter- and intracellular signals in-
volved in branching morphogenesis, mesenchyme to epithe-
lium transitions, vasculogenesis, and cell type-specific gene
expression. In the mouse, kidney development begins on the
eleventh day of gestation when the ureteric bud, an out-
growth of the Wolffian duct, is induced to grow towards and
invade the metanephric mesenchyme (MM)* (Fig. 1). The
MM is a distinct population of loosely arranged mesoderm-
derived cells that are determined to form nephrons, the indi-
vidual filtration units of the definitive (metanephric) kidney.
 
When the ureteric bud invades the MM, it induces condensa-
tion, epithelialization, and nephron formation in a subset of
the MM. In turn, signals from the MM induce the ureteric
bud to branch and grow (Fig. 1), whereupon a new population
of MM is induced to form nephrons. This cycle of reciprocal
 
interactions between the ureteric bud and the MM continues
throughout gestation and for several weeks postnatally to
 
eventually form 
 
 
 
1,500 nephrons per kidney in the mouse
(Saxen, 1987; for review see Davies and Bard, 1998).
The generation and analysis of mice bearing targeted muta-
tions has been especially instrumental in defining the repertoire
of proteins that play important roles in kidney development.
Members of many well-known gene families involved in di-
verse biological pathways have been shown to be required
for normal kidney development (for review see Kuure et al.,
2000). These include the Wilms’ tumor suppressor protein
(WT-1), the receptor tyrosine kinase c-ret, its ligand, glial
cell line–derived neurotrophic factor, Pax-2, Eya-1, Emx-2,
BF-2, Pod1, Lmx1b, p53, BMPs, FGFs, Wnts, Hox pro-
teins, cadherins, integrins, and laminins. In some cases, the
mutated gene of interest was not known or predicted to be
involved in kidney development. In one example, mice with
a mutation in the gene encoding heparan sulfate 2–sul-
fotransferase, an enzyme involved in proteoglycan synthesis,
exhibit renal agenesis due to failure of ureteric bud out-
growth (Bullock et al., 1998). This indicates an important
role for one or more sulfated proteoglycans either in the ex-
tracellular matrix or on the cell surface. Similar scenarios will
likely recur frequently as large scale mouse mutagenesis
screens come to fruition.
One such scenario transpired when a targeted mutation in
 
the integrin 
 
 
 
8 chain gene (
 
Itga8
 
) was generated (Muller et al.,
1997). At the time, integrin 
 
 
 
8 was known to be expressed on
the surface of sensory, motor, and other neurons, especially at
sites of apposition of their axons to basement membranes. Be-
cause 
 
 
 
8
 
 
 
1 bound several matrix components, including fi-
bronectin, vitronectin, and tenascin-C (Muller et al., 1995;
Schnapp et al., 1995; Varnum-Finney et al., 1995), the expec-
tation was that mutants would have defects in the nervous sys-
tem, perhaps in outgrowth or pathfinding. Surprisingly, most
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Itga8
 
 
 
/
 
 
 
 mice lacked kidneys and died shortly after birth.
(Kidney function is not required in utero but is required post-
natally.) However, 
 
 
 
32% of homozygotes had at least one
kidney, which was smaller than those observed in wild-type
mice but nevertheless was functional in a subset of cases. This
resulted in a cohort of 
 
Itga8
 
 
 
/
 
 
 
 mice with one kidney that
were viable and fertile. No neuronal defects have been re-
ported in these mutants, but significant defects were found in
a subset of vestibular hair cells (Littlewood Evans and Muller,
2000). Despite the presence of functional kidneys in some
 
Itga8
 
 mutants, these data showed that integrin 
 
 
 
8 plays an im-
portant role in kidney development (Muller et al., 1997).
 
In an attempt to define the role of integrin 
 
 
 
8 in kidney
development, its expression patterns at early stages of meta-
nephrogenesis in wild-type kidney were determined by im-
munohistochemistry (Muller et al., 1997). Integrin 
 
 
 
8 was
clearly expressed on the surface of the induced condensing
MM and was also concentrated on the mesenchymal cells ad-
jacent to proximal segments of the ureteric bud (Fig. 1, B and
C). Once the condensed MM epithelialized, integrin 
 
 
 
8 was
no longer detectable. In addition, there was no evidence that
the ureteric bud epithelial cells expressed integrin 
 
 
 
8. The
straightforward interpretation of these results is that binding
of integrin 
 
 
 
8 on the surface of cells in the MM to a ligand
synthesized by the ureteric bud is critical for normal kidney
development. The interaction may be necessary to induce or
maintain signaling from the MM to the ureteric bud. Alter-
natively, the interaction itself may result in a conformational
change in the ligand, perhaps altering its functional proper-
ties. This could affect ureteric bud outgrowth either directly
via a different receptor or indirectly by increasing the concen-
tration or accessibility of critical factors secreted by the MM
such as glial cell line–derived neurotrophic factor.
Although it is relatively simple to explain how an integrin
on cells in the MM might influence ureteric bud branching
and outgrowth within the metanephros, it is more difficult
to understand how it could promote initial bud outgrowth
from the Wolffian duct towards the MM, a process which is
slowed in the 
 
Itga8
 
 mutants. This difficulty arises because:
(a) the MM is not in direct contact with the Wolffian duct
and (b) uninduced MM does not even express integrin 
 
 
 
8
(Muller et al., 1997). However, expression of integrin 
 
 
 
8 by
mesenchymal cells directly adjacent to the Wolffian duct
and the nascent ureteric bud could promote bud outgrowth
by the same mechanisms discussed above, assuming the
ligand is present at early stages of bud outgrowth (and it ap-
pears to be; see below). Whatever the mechanism, in order
to determine how integrin 
 
 
 
8 acts the identity of the ligand
needed to be determined.
Could it be one of the known 
 
 
 
8
 
 
 
1 ligands? Three of the
known ligands, fibronectin, vitronectin, and tenascin-C, were
not deposited appropriately in the developing kidney to be
considered likely candidates (Muller et al., 1997). A fourth
ligand, osteopontin, was expressed in the developing kidney,
but mutation of its gene showed that it was not required for
kidney development in vivo (Denda et al., 1998; Liaw et al.,
1998). By using a soluble alkaline phosphatase-tagged 
 
 
 
8
 
 
 
1
dimer (
 
 
 
8
 
 
 
1-AP), which presumably bound to the same
ligand(s) as the endogenous 
 
 
 
8
 
 
 
1, the putative ligand was lo-
calized in the developing kidney adjacent to the ureteric bud
in a pattern consistent with its being present in the ureteric
bud basement membrane (Muller et al., 1997). The putative
ligand was therefore present exactly where it needed to be in
order to interact with integrin 
 
 
 
8
 
 
 
1 on the surface of mesen-
chymal cells. Furthermore, on a blot the soluble 
 
 
 
8
 
 
 
1-AP
bound in an arginine-glycine-aspartic acid (RGD)–dependent
fashion to several proteins from embryonic kidney, including
a major band at 60–90 kD, which did not correspond to the
known ligands (Muller et al., 1997). This suggested that a
novel ligand for 
 
 
 
8
 
 
 
1 existed in developing kidney.
In this issue, Brandenberger et al. (2001) report the iden-
tification and characterization of this novel ligand, neph-
Figure 1. Schematic representation of early kidney development 
with known and hypothesized locations of nephronectin (yellow) 
and integrin  8 (red) indicated. The interaction of integrin  8-
expressing mesenchymal cells with nephronectin in the ureteric bud 
basement membrane is critical for normal ureteric bud outgrowth 
and branching. (A) Embryonic day (e) 10.5. The ureteric bud (UB) 
has just begun to bud from the Wolffian duct (WD). Nephronectin is 
associated with the Wolffian duct and ureteric bud basement mem-
branes. Integrin  8 is present on the mesenchymal cells immediately 
adjacent to basement membranes and elsewhere in the urogenital 
ridge but not in the MM. (B) e11. The ureteric bud has invaded the 
MM. Integrin  8 now becomes detectable on the condensing cells 
in the MM near the tip of the bud. (C) e11.5. The MM has induced 
the ureteric bud to branch. Nephronectin is found throughout the 
ureteric bud basement membrane, and mesenchymal cells express-
ing integrin  8 are found both along the proximal stalk of the ure-
teric bud and adjacent to the branched ureteric bud.
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ronectin. By using the soluble 
 
 
 
8
 
 
 
1-AP as a specific probe,
cDNAs encoding nephronectin were isolated from a bacte-
riophage expression library. Based on the deduced amino
acid sequence, nephronectin is a novel secreted protein,
which contains an RGD sequence, five epidermal growth
factor–like repeats, and a COOH-terminal domain with ho-
mology to MAM repeats. Both epidermal growth factor–like
and MAM repeats are thought to mediate protein–protein
interactions, so nephronectin likely interacts with itself or
with other proteins in the extracellular matrix.
By generating antisera to nephronectin, Brandenberger et
al. (2001) show that it is deposited in the developing kidney
in a pattern similar to that revealed by the 
 
 
 
8
 
 
 
1-AP probe,
primarily in the ureteric bud basement membrane but also
in the Wolffian duct basement membrane (Fig. 1) and at low
levels in primitive nephron structures. Surprisingly, neph-
ronectin was detected strongly in the glomerular basement
membrane of maturing glomeruli. The glomerulus is that
part of the nephron where filtration occurs, and the glomeru-
lar basement membrane is one important component of the
filtration barrier. Therefore, nephronectin may play a role in
establishing or maintaining the filtration barrier. However,
integrin 
 
 
 
8 is not associated with glomerular cells at this
stage (Muller et al., 1997). Thus, there may be a receptor
other than integrin 
 
 
 
8 on glomerular cells that mediates in-
teractions with nephronectin. One possibility is integrin 
 
 
 
3,
which is expressed by podocytes (glomerular epithelial cells)
and required for formation of the glomerular filtration
barrier (Kreidberg et al., 1996). However, integrin 
 
 
 
3
 
 
 
1-
expressing cells did not adhere to an RGD-containing fragment
of nephronectin (Brandenberger et al., 2001). Nevertheless,
its binding site may be elsewhere in nephronectin, as 
 
 
 
3
 
 
 
1 is
not a classic RGD-binding integrin. Cells expressing 
 
 
 
V in-
tegrins did bind to the nephronectin fragment (Branden-
berger et al., 2001), so it is possible that 
 
 
 
V integrins on
glomerular endothelial cells mediate their binding to neph-
ronectin in the glomerular basement membrane.
The expression pattern of nephronectin in the ureteric
bud and Wolffian duct is similar to that of laminin-10, com-
posed of the laminin 
 
 
 
5,
 
  
 
1, and 
 
 
 
1 chains (Miner et al.,
1997; Sorokin et al., 1997). Knockout mice lacking the
laminin 
 
 
 
5 chain have multiple defects in kidney develop-
ment, including uni- or bilateral renal agenesis in 
 
 
 
20% of
mutant embryos. This was associated with defective ureteric
bud outgrowth and branching (Miner and Li, 2000). As
nephronectin and laminin-10 appear to be colocalized in the
Wolffian duct and ureteric bud basement membranes, it is
possible that they may interact with each other and/or co-
operate to promote efficient ureteric bud outgrowth and
branching, either through parallel or common pathways. Al-
ternatively, they may work synergistically with the other ma-
trix molecules and receptors known to be involved in kidney
development (for review see Muller and Brandli, 1999).
Despite its nephro-centric moniker, nephronectin expres-
sion is not restricted to the kidney. Immunohistochemical as-
says demonstrate that it is widely expressed during develop-
ment, in most cases associated with basement membranes
(Brandenberger et al., 2001). Might nephronectin have a role
in the development of other organs? A genetic analysis of
nephronectin function will hopefully answer this question and
 
further elucidate the role of the integrin 
 
 
 
8
 
 
 
1–nephronectin
interaction in ureteric bud outgrowth and nephrogenesis.
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